Article Publish Status: FREE
Abstract Title:

Extract WS®1442 Stimulates Cardiomyogenesis and Angiogenesis From Stem Cells: A Possible New Pharmacology for Hawthorn?

Abstract Source:

Front Pharmacol. 2019 ;10:1357. Epub 2019 Nov 27. PMID: 31849643

Abstract Author(s):

Jonas Halver, Kristin Wenzel, Jandirk Sendker, Carmen Carrillo García, Clemens A J Erdelmeier, Erik Willems, Mark Mercola, Nico Symma, Stephanie Könemann, Egon Koch, Andreas Hensel, Dennis Schade

Article Affiliation:

Jonas Halver


Extracts from the leaves and flowers ofspp. (i.e., hawthorn species) have been traditionally used with documented preclinical and clinical activities in cardiovascular medicine. Based on reported positive effects on heart muscle after ischemic injury and the overall cardioprotective profile, the present study addressed potential contributions ofextracts to cardiopoietic differentiation from stem cells. The quantifiedextract WS1442 stimulated cardiomyogenesis from murine and human embryonic stem cells (ESCs). Mechanistically, this effect was found to be induced by promoting differentiation of cardiovascular progenitor cell populations but not by proliferation. Bioassay-guided fractionation, phytochemical and analytical profiling suggested high-molecular weight ingredients as the active principle with at least part of the activity due to oligomeric procyanidines (OPCs) with a degree of polymerization between 3 and 6 (DP3-6). Transcriptome profiling in mESCs suggested two main, plausible mechanisms: These were early, stress-associated cellular events along with the modulation of distinct developmental pathways, including the upregulation of brain-derived neurotrophic factor (BDNF) and retinoic acid as well as the inhibition of transforming growth factorβ/bone morphogenetic protein (TGFβ/BMP) and fibroblast growth factor (FGF) signaling. In addition, WS1442 stimulated angiogenesisin Sca-1progenitor cells from adult mice hearts. Thesedata provide evidence for a differentiation promoting activity of WS1442 on distinct cardiovascular stem/progenitor cells that could be valuable for therapeutic heart regeneration after myocardial infarction. However, therelevance of this new pharmacological activity ofspp. remains to be investigated and active ingredients from bioactive fractions will have to be further characterized.

Study Type : In Vitro Study

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2022 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.